About Pricing FAQs Providers Trials Blog

Back to your record

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clinical Trial to Evaluate the Efficacy and Security of Deep Brain Stimulation in Alzheimer´s Disease

NCT03290274·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Aurora Viloria, MD
CONTACT
+34913003306 mariaaurora.viloria@salud.madrid.org

Lead

Hospital San Carlos, Madrid

Age

50–80

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

Age: Between 50-80 years old
Diagnosis criteria of Alzheimer disease (Dubois criteria) in the previous 2 years
Presence of tau, p-tau or Aβ in cerebrospinal fluid or positive amiloid-PET scan
Clinical dementia rating scale (CDR): 1
Use of cholinesterase inhibitors and/or memantine during one year at least, and worsening in neuropsychologic tests in spite of the treatment
Informed consent (patient and caregiver or legal representative)

You may not be if

Brain structural disorders: primary or metastatic tumor, Hydrocephalus, stroke, brain abscess or cerebral malformation
Vascular dementia (NINCDS-AIREN criteria)
Neurodegenerative disease other than AD
Psychiatric disease
Epilepsy
Severe or unstable comorbidity (mellitus diabetes, high blood pressure…)

The record

StatusUnknown

PhaseNot applicable

Taking part6

StartedMar 2017

UpdatedSep 21, 2017

Conditions

Alzheimer Disease

Where1

Hospital Clinico San Carlos
Madrid, Spain